Eleanor Mills was a woman living with significant bone loss who saw herself as “a bent lady looking like an inverted L” after sustaining multiple osteoporotic fractures. Her daughter, Helen, […]

OUR IMPACT Osteoporosis Canada’s latest Impact Report is now available. This report highlights the organization’s significant achievements over the past year towards the vision of a Canada without osteoporotic fractures. […]

Members of Osteoporosis Canada’s Scientific Advisory Council would like announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. Osteoporosis Canada established this award in 1993 […]

On behalf of Osteoporosis Canada’s Scientific Advisory Consultants and Osteoporosis Canada, we would like to announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. […]

SERMS Selective Estrogen Receptor Modulators Raloxifene (Evista®) is from a family of drugs called SERMs (Selective Estrogen Receptor Modulators). How Does Raloxifene Work? During their reproductive years, women produce significant […]

Hip Fractures Hip fractures from osteoporosis are usually the result of a fall and most commonly occur in people in their late 70s or 80s. A broken hip will require hospitalization and […]

Dr. Adrian Lau, Dr. Rowena Ridout, Dr. Claudia Gagnon, Dr. Zahra Bardai, and Dr. Emma Billington. Recommendations from Osteoporosis Canada Rapid Response Team. The Canadian Centre on Substance Use and […]

VITAMIN D IS VERY IMPORTANT TO OUR BONE HEALTH When taken in the appropriate amount, vitamin D decreases our risk of falling and breaking bones. It is very common to […]

BISPHOSPHONATES The most common family of drugs used to treat osteoporosis Bisphosphonates are the most common family of drugs used to treat osteoporosis. They are part of the group of […]